Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism

Background: Testosterone replacement therapy (TRT) is one of the main lines of treatment for men with hypogonadism. This study sought to evaluate the influence of TRT in men with late-onset hypogonadism (LOH), regarding fatigue, coronary artery disease (CAD), carotid intima-media thickness (CIMT) an...

Full description

Bibliographic Details
Main Authors: Maurício de Almeida Ferreira, José Alexandre Mendonça
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2022-02-01
Series:Drugs in Context
Subjects:
fatigue
heart disease risk factors
hypogonadism
testosterone
Online Access:https://www.drugsincontext.com/long-term-testosterone-replacement-therapy-reduces-fatigue-in-men-with-hypogonadism

Internet

https://www.drugsincontext.com/long-term-testosterone-replacement-therapy-reduces-fatigue-in-men-with-hypogonadism

Similar Items